EGFR and neoplasm: miRNAs: miR-342-5p post-transcriptionally inhibits BCL2L1 mRNA in SW1353 chondrosarcoma cells, while miR-491-5p inhibits epidermal growth factor receptor (EGFR) expression, whose spontaneous activation in the absence of ligand is associated with tumor progression.